menu
    • menu

    Company profile for Canntab Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Canntab Therapeutics is the industry leader in solid oral dose formulations of cannabis with a product line of cannabinoid (THC & CBD) and terpenoid blends in exacting dosages. A clear and sustainable competitive advantage with 13 patents pending in Canada and the United States covering our proprietary processes and solid oral dose formulations for extended release, immediate release, flash melt and bi-layered medications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Canntab TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Research and Development, Markham, Ontario Manufacturing Facility, Cobourg, On...
    Telephone
    Telephone
    (289) 301-3812
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://canntab.ca/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/canntab-therapeutics-ltd
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Canntab_

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Canntab Announces Corporate Update
    Canntab Announces Corporate Update

    22 Nov 2022

    // ACCESSWIRE

    https://www.accesswire.com/727653/Canntab-Announces-Corporate-Update

    ACCESSWIRE
    22 Nov 2022
    Share Share
    Canntab Signs Historic Agreement With First Nations Growers Gp
    Canntab Signs Historic Agreement With First Nations Growers Gp

    07 Feb 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/canntab-signs-historic-agreement-with-first-nations-growers-gp-inc-to-address-the-opiate-and-illicit-drug-crisis-affecting-indigenous-peoples-throughout-canada-301476413.html

    PRNEWSWIRE
    07 Feb 2022
    Share Share
    Canntab Announces Closing Of Convertible Debenture Private Placement
    Canntab Announces Closing Of Convertible Debenture Private Placement

    01 Feb 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/canntab-announces-closing-of-convertible-debenture-private-placement-warrant-expiry-extension-and-corporate-update-301473454.html

    PRNEWSWIRE
    01 Feb 2022
    Share Share
    Canntab Granted 3rd Patent and Receives $400K Purchase Order in Australia
    Canntab Granted 3rd Patent and Receives $400K Purchase Order in Australia

    09 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/canntab-granted-3rd-patent-and-receives-400k-purchase-order-in-australia-301242928.html

    PRNEWSWIRE
    09 Mar 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search